About Caladrius

Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company with multiple technology platforms targeting select cardiovascular indications and autoimmune diseases.

News

August 30, 2018
Caladrius Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

August 9, 2018
Caladrius Biosciences Reports 2018 Second Quarter and First Six Months Financial Results

August 2, 2018
Caladrius Biosciences to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 9, 2018 at 4:30 p.m. ET

Events

September 5, 2018
Caladrius Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

August 9, 2018
Second Quarter 2018 Financial Results Call

May 10, 2018
First Quarter 2018 Financial Results Call

Sign up to our e-mail list to receive Caladrius announcements.

Technologies & Capabilities

T Regulatory Cell Technology

T Regulatory Cell Technology

CD34 Cell Technology

CD34 Cell Technology